Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells.
Epidemiological studies indicate that metformin, a widely used type 2 diabetes drug, might reduce breast cancer risk and mortality in patients with type 2 diabetes. Metformin might protect against breast cancer indirectly by ameliorating systemic glucose homeostasis. Alternatively, it might target b...
Main Authors: | Maruša Rajh, Klemen Dolinar, Katarina Miš, Mojca Pavlin, Sergej Pirkmajer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4852933?pdf=render |
Similar Items
-
Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
by: Maruša Bizjak, et al.
Published: (2017-05-01) -
Quantitative Structure–Activity Relationship Evaluation of MDA-MB-231 Cell Anti-Proliferative Leads
by: Ajaykumar Gandhi, et al.
Published: (2021-08-01) -
Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α
by: Nives Škorja Milić, et al.
Published: (2021-08-01) -
Potential Effects of Chrysin on MDA-MB-231 Cells
by: Maimunah Ahmad, et al.
Published: (2010-03-01) -
The anti proliferative effect of Aloin and Aloe emodin on MCF-7 and MDA-MB-231 breast cancer cells
by: Daud, MM, et al.